Search Results - "Malkowicz, S B"

Refine Results
  1. 1
  2. 2

    Does Race Affect Postoperative Outcomes in Patients With Low-Risk Prostate Cancer Who Undergo Radical Prostatectomy? by Resnick, M.J, Canter, D.J, Guzzo, T.J, Brucker, B.M, Bergey, M, Sonnad, S.S, Wein, A.J, Malkowicz, S.B

    Published in Urology (Ridgewood, N.J.) (01-03-2009)
    “…Objectives To assess the magnitude of racial disparities in prostate cancer outcomes following radical prostatectomy for low-risk prostate cancer. Methods We…”
    Get full text
    Journal Article
  3. 3

    Modification of Clinical Presentation of Prostate Tumors by a Novel Genetic Variant in CYP3A4 by Rebbeck, Timothy R., Jaffe, Julie M., Walker, Amy H., Wein, Alan J., Malkowicz, S. Bruce

    “…Background: Pathways involved in androgen metabolism have been implicated in the etiology of prostate cancer. The goal of this study was to evaluate the effect…”
    Get full text
    Journal Article
  4. 4

    Toremifene increases bone mineral density in men receiving androgen deprivation therapy for prostate cancer: interim analysis of a multicenter phase 3 clinical study by Smith, M R, Malkowicz, S B, Chu, F, Forrest, J, Price, D, Sieber, P, Barnette, K G, Rodriguez, D, Steiner, M S

    Published in The Journal of urology (01-01-2008)
    “…We evaluated the effects of toremifene on bone mineral density, a surrogate for fracture risk, in men receiving androgen deprivation therapy for prostate…”
    Get more information
    Journal Article
  5. 5
  6. 6

    Pretreatment Nomogram for Prostate-Specific Antigen Recurrence After Radical Prostatectomy or External-Beam Radiation Therapy for Clinically Localized Prostate Cancer by D'AMICO, A. V, WHITTINGTON, R, COLEMAN, C. N, MALKOWICZ, S. B, FONDURULIA, J, CHEN, M.-H, KAPLAN, I, BEARD, C. J, TOMASZEWSKI, J. E, RENSHAW, A. A, WEIN, A

    Published in Journal of clinical oncology (01-01-1999)
    “…To present nomograms providing estimates of prostate-specific antigen (PSA) failure-free survival after radical prostatectomy (RP) or external-beam radiation…”
    Get full text
    Journal Article
  7. 7

    Paclitaxel plus carboplatin in advanced carcinoma of the urothelium: an active and tolerable outpatient regimen by Vaughn, D J, Malkowicz, S B, Zoltick, B, Mick, R, Ramchandani, P, Holroyde, C, Armstead, B, Fox, K, Wein, A

    Published in Journal of clinical oncology (01-01-1998)
    “…To determine the toxicity and efficacy of an outpatient regimen of paclitaxel plus carboplatin in patients with advanced carcinoma of the urothelium. Patients…”
    Get more information
    Journal Article
  8. 8

    The role of diethylstilbestrol in the treatment of prostate cancer by Malkowicz, S.Bruce

    Published in Urology (Ridgewood, N.J.) (01-08-2001)
    “…Objectives: Diethylstilbestrol administration was a classic form of androgen deprivation therapy (ADT) that gradually fell out of favor because of its…”
    Get full text
    Journal Article
  9. 9

    A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer by D'Amico, A V, Whittington, R, Malkowicz, S B, Schultz, D, Schnall, M, Tomaszewski, J E, Wein, A

    Published in The Journal of urology (01-07-1995)
    “…A Cox regression multivariate analysis was done to determine the clinical and pathological indicators that predict for prostate specific antigen (PSA) failure…”
    Get more information
    Journal Article
  10. 10

    Clinical characteristics of prostate cancer in African Americans, American whites, and Senegalese men by Gueye, S.M, Zeigler-Johnson, C.M, Friebel, T, Spangler, E, Jalloh, M, MacBride, S, Malkowicz, S.B, Rebbeck, T.R

    Published in Urology (Ridgewood, N.J.) (01-05-2003)
    “…To describe the clinical features of prostate cancer in Senegalese men and compare these features with those found in African-American and white American men…”
    Get full text
    Journal Article
  11. 11

    Preemptive Epidural Analgesia and Recovery From Radical Prostatectomy: A Randomized Controlled Trial by Gottschalk, Allan, Smith, David S, Jobes, David R, Kennedy, Sean K, Lally, Sara E, Noble, Vicki E, Grugan, Kathy F, Seifert, Harry A, Cheung, Albert, Malkowicz, S. Bruce, Gutsche, Brett B, Wein, Alan J

    “…CONTEXT.— Preemptive analgesia can decrease the sensitization of the central nervous system that would ordinarily amplify subsequent nociceptive input, but a…”
    Get full text
    Journal Article
  12. 12

    Association of prostate cancer family history with histopathological and clinical characteristics of prostate tumors by Spangler, E., Zeigler‐Johnson, C.M., Malkowicz, S.B., Wein, A.J., Rebbeck, T.R.

    Published in International journal of cancer (20-01-2005)
    “…Genetic factors may be used not only to assess risk of prostate cancer development but also to evaluate prostate cancer outcomes including clinical prognosis,…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Prostate-specific antigen failure despite pathologically organ-confined and margin-negative prostate cancer: the basis for an adjuvant therapy trial by D'Amico, A V, Whittington, R, Malkowicz, S B, Schultz, D, Tomaszewski, J E, Wein, A

    Published in Journal of clinical oncology (01-04-1997)
    “…A multivariable analysis to evaluate the potential clinical and pathologic factors that predict for early biochemical failure in patients with pathologically…”
    Get more information
    Journal Article
  15. 15

    Association of SRD5A2 genotype and pathological characteristics of prostate tumors by JAFFE, J. M, MALKOWICZ, S. B, WALKER, A. H, MACBRIDE, S, PESCHEL, R, TOMASZEWSKI, J, VAN ARSDALEN, K, WEIN, A. J, REBBECK, T. R

    Published in Cancer research (Chicago, Ill.) (15-03-2000)
    “…The enzyme product of SRD5A2, 5alpha-reductase type II, is responsible for converting testosterone to the more metabolically active dihydrotestosterone…”
    Get full text
    Journal Article
  16. 16

    The application of human complement factor H-related protein (BTA TRAK) in monitoring patients with bladder cancer by Malkowicz, S B

    Published in Urologic clinics of North America (01-02-2000)
    “…The BTA TRAK assay is a quantitative sandwich format enzyme immunoassay performed in a reference laboratory. It measures levels of human complement factor…”
    Get more information
    Journal Article
  17. 17

    Erectile function and quality of life after interstitial radiation therapy for prostate cancer by SANCHEZ-ORTIZ, R. F, BRODERICK, G. A, ROVNER, E. S, WEIN, A. J, WHITTINGTON, R, MALKOWICZ, S. B

    “…Few studies have evaluated erectile function after interstitial radiation therapy for localized prostate cancer. Using a validated quality of life…”
    Get full text
    Conference Proceeding Journal Article
  18. 18
  19. 19

    Ethnic differences in the frequency of prostate cancer susceptibility alleles at SRD5A2 and CYP3A4 by Zeigler-Johnson, C M, Walker, A H, Mancke, B, Spangler, E, Jalloh, M, McBride, S, Deitz, A, Malkowicz, S B, Ofori-Adjei, D, Gueye, S M, Rebbeck, T R

    Published in Human heredity (01-01-2002)
    “…Ethnic differences in prostate cancer incidence are well documented, with African-Americans having among the highest rates in the world. Ethnic differences in…”
    Get more information
    Journal Article
  20. 20

    Endorectal coil magnetic resonance imaging identifies locally advanced prostate cancer in select patients with clinically localized disease by D'Amico, Anthony V., Schnall, Mitchell, Whittington, Richard, Malkowicz, S.Bruce, Schultz, Delray, Tomaszewski, John E., Wein, Alan

    Published in Urology (Ridgewood, N.J.) (01-03-1998)
    “…Objectives. Endorectal coil magnetic resonance imaging (erMRI) has been reported to improve the prediction of pathologic Stage T3 disease in patients with…”
    Get full text
    Journal Article